About

Natan Ponieman is a writer, journalist and filmmaker covering psychedelics as they intersect with finance, culture, science, politics and spirituality. He's a Forbes Contributor and serves as Head of Psychedelics Content at Benzinga. His work has been featured in Entrepreneur Magazine, Yahoo Finance, Benzinga, MSN Money, Leafly News, High Times and many others.

Natan's Certified Posts

Introducing the Ketamine Industry’s Most Comprehensive Professional Liability Coverage

Most ketamine clinics think their liability insurance their ketamine treatments -- but for most it doesn't. We solved this problem.

Read More

Introducing The Healing Health Alliance – The First GPO for the Ketamine Industry

We are launching the Healing Health Alliance -- the ketamine industry's first GPO -- which will save clinics up to

Read More

Interested in the Ketamine Industry? We’ve Created the First Newsletter For You

Introducing Ketamine Insights Weekly, a new newsletter created specifically for the ketamine clinic and therapy industry.

Read More

Natan's Posts

What Is A K-Hole? What it Feels Like and How You Can Get There

What is a k-hole? This guide explains the possible “ego-dissolution” that comes from ketamine.

Read More

Klee Irwin And His Plan To Bring Psychedelic Therapy To The Masses

Businessman Klee Irwin explains his plan to “bring psychedelics therapy to the masses.”

Read More

Psychedelics in Therapy – The Next Generation of Treatment

Can the use of psychedelics in therapy settings change mental health as we know it?

Read More

San Pedro Cactus (Echinopsis Pachanoi) – Uses, Legality And More

The San Pedro cactus has a rich history, and this helps explain the hallucinogenic plant.

Read More

What Is Bicycle Day – The World’s Biggest Psychedelic Holiday?

Bicycle Day has become a celebrated holiday each year for psychedelic enthusiasts.

Read More

Legal Psychedelics In U.S. 2024: Decriminalized LSD, Psilocybin & More

Some U.S. cities have passed legislation for legal psychedelics to be decriminalized. Here's what to know.

Read More